[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

A key Centers for Disease Control and Prevention advisory panel is holding a meeting Wednesday to discuss rare, but higher-than-expected, reports of heart inflammation in 16- to 24-year-olds after receiving their second dose of Pfizer's or Moderna's Covid-19 vaccines.